Non-Invasive Drug Delivery Systems for the Management of Postoperative Pain

[1]  M. Ashburn,et al.  The clinical evaluation of the compassionate use of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain , 1990, Pain.

[2]  M. Ashburn,et al.  Oral transmucosal fentanyl citrate for premedication in paediatric outpatients , 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[3]  M. Ashburn,et al.  A783 ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC)FOR THE TREATMENT OF POSTOPERATIVE PAIN , 1990 .

[4]  M. Ashburn,et al.  Oral Transmucosal Fentanyl Citrate For Analgesia And Anxiolysis In The Emergency Room , 1990 .

[5]  H. Owen,et al.  The efficacy of transdermal fentanyl in the treatment of postoperative pain: a double-blind comparison of fentanyl and placebo systems , 1990, Pain.

[6]  M. Ashburn,et al.  Oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: a case report. , 1989, Anesthesiology.

[7]  M. Ashburn,et al.  BIOAVAILABILITY AND ABSORPTION OF ORAL TRANSMUCOSAL FENTANYL CITRATE , 1989 .

[8]  T. Stanley,et al.  Opioids: new techniques in routes of administration , 1989 .

[9]  K. A. East,et al.  Oral Transmucosal Fentanyl Citrate (Lollipop) Premedication in Human Volunteers , 1989, Anesthesia and analgesia.

[10]  J. Plummer,et al.  The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects , 1989, Pain.

[11]  N. Pace,et al.  Comparison of oral transmucosal fentanyl citrate and an oral solution of meperidine, diazepam, and atropine for premedication in children. , 1989, Anesthesiology.

[12]  G. Park,et al.  Absorption of buccal morphine , 1989, Anaesthesia.

[13]  R. Caplan,et al.  Transdermal fentanyl for postoperative pain management. A double-blind placebo study. , 1989, JAMA.

[14]  S. Jacobsen,et al.  Painless cauterization of spider veins with the use of iontophoretic local anesthesia. , 1988, Journal of the American Academy of Dermatology.

[15]  M. Vercauteren,et al.  INTRANASAL SUFEN-TANIL FOR PREOPERATIVE SEDATION , 1988 .

[16]  M. Ashburn,et al.  CONTROLLED IONTOPHORETIC DELIVERY OF MORPHINE HCL FOR POST-OPERATIVE PAIN RELIEF , 1988 .

[17]  K. Foley,et al.  Sublingual absorption of selected opioid analgesics , 1988, Clinical pharmacology and therapeutics.

[18]  M. Hanna,et al.  Absorption of buccal morphine , 1988, Anaesthesia.

[19]  J. Henderson,et al.  Pre‐induction of Anesthesia in Pediatric Patients with Nasally Administered Sufentanil , 1988, Anesthesiology.

[20]  F. Holley,et al.  Postoperative analgesia with fentanyl: pharmacokinetics and pharmacodynamics of constant-rate i.v. and transdermal delivery. , 1988, British journal of anaesthesia.

[21]  D. Rowbotham,et al.  Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. , 1988, British journal of anaesthesia.

[22]  M. Vercauteren,et al.  Intranasal sufentanil for pre‐operative sedation , 1988, Anaesthesia.

[23]  M. Hanna,et al.  Buccal morphine premedication , 1986, Anaesthesia.

[24]  F. Holley,et al.  TRANSDERMAL ADMINISTRATION OF FENTANYL FOR POSTOPERATIVE ANALGESIA , 1986 .

[25]  J. Schmidt,et al.  Sublingual Buprenorphine for Premedication and Postoperative Pain Relief in Orthopaedic Surgery , 1985, Acta anaesthesiologica Scandinavica.

[26]  G. R. Murray,et al.  BUCCAL MORPHINE—A NEW ROUTE FOR ANALGESIA? , 1985, The Lancet.

[27]  J. M. Bradley,et al.  Effect of exchange-reduction transfusion on carbamazepine. , 1984, Clinical pharmacy.

[28]  J. Iwiński,et al.  Mini set for iontophoresis for topical analgesia before injection. , 1984, International journal of clinical pharmacology, therapy, and toxicology.

[29]  L. Bertolucci.  Introduction of Antiinflammatory Drugs by lontophoresis: Double Blind Study. , 1982, The Journal of orthopaedic and sports physical therapy.

[30]  P. Harris.  Iontophoresis: Clinical Research in Musculoskeletal Inflammatory Conditions , 1982 .

[31]  F. Pannuti,et al.  Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route Pharmacol. Res. Commun., 14 (1982) 369–380 , 1982, Pain.

[32]  F. Delacerda.  A comparative study of three methods of treatment for shoulder girdle myofascial syndrome. , 1982, The Journal of orthopaedic and sports physical therapy.

[33]  R. Moore,et al.  Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis. , 1982, British journal of clinical pharmacology.

[34]  F. Pannuti,et al.  Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route. Clinical report and preliminary results on morphine pharmacokinetics. , 1982, Pharmacological research communications.

[35]  S. Jacobson,et al.  The Quantity and Distribution of Radiolabeled Dexamethasone Delivered to Tissue by Iontophoresis , 1980, International journal of dermatology.

[36]  G. Cooper,et al.  Analgesic effects of sublingual buprenorphine , 1979, Anaesthesia.

[37]  D. Freestone,et al.  The administration of drugs and vaccines by the intranasal route. , 1976, British journal of clinical pharmacology.

[38]  N. W. Johnson,et al.  Permeability of oral mucosa. , 1975, British medical bulletin.

[39]  D. Klarkowski,et al.  Donor blood frozen and stored between -20 degrees C and -25 degrees C with 35-day post-thaw shelf life. , 1989, Lancet.